The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
Ā© 2024 TheOutpost.AI All rights reserved
Curated by THEOUTPOST
On July 17, 2024
2 Sources
[1]
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024 By Investing.com
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (Allurion or the Company), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion's Investor Relations website at Allurion - Events & Presentations. A replay of the conference call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion's Investor Relations website mentioned above. About Allurion Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world's first and only swallowable, Procedurelessā¢ intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States. For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com. Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.
[2]
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion's Investor Relations website at Allurion - Events & Presentations. A replay of the conference call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion's Investor Relations website mentioned above. About Allurion Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world's first and only swallowable, Procedurelessā¢ intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States. For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com. Allurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.
Share
Share
Copy Link
Allurion Technologies, a leader in weight loss technology, has scheduled its second quarter 2024 financial results announcement for August 13, 2024. The company will host a conference call and webcast to discuss the results.
Allurion Technologies, Inc. (NYSE: ALUR), a prominent player in the weight loss technology sector, has announced that it will release its financial results for the second quarter of 2024 on Tuesday, August 13, 2024 1. The company, known for its innovative approaches to weight loss, has scheduled this announcement before the U.S. financial markets open.
Following the release of the financial results, Allurion will host a conference call and live webcast at 8:30 a.m. Eastern Time on the same day 2. This event will provide an opportunity for investors, analysts, and interested parties to delve deeper into the company's performance and future outlook.
For those wishing to participate in the conference call, the following details have been provided:
These access numbers will allow participants to join the call and engage with Allurion's management team during the discussion [1].
In addition to the conference call, Allurion will also be hosting a live webcast of the event. This webcast can be accessed through the "Events and Presentations" section of Allurion's Investor Relations website at investors.allurion.com [2]. This option provides an alternative for those who prefer to follow the proceedings online.
For those unable to attend the live event, Allurion has made provisions for a replay of the conference call. The replay will be available approximately three hours after the call concludes and can be accessed until August 27, 2024 [1]. To access the replay, interested parties can use the following details:
This upcoming financial results announcement is significant for Allurion Technologies and its stakeholders. As a company traded on the New York Stock Exchange under the ticker symbol ALUR, these quarterly results provide crucial insights into the company's financial health, operational performance, and strategic direction [2]. The results will likely be closely watched by investors, analysts, and industry observers to gauge Allurion's progress in the competitive weight loss technology market.
Reference
[1]
[2]
Veracyte, Inc., a leading genomic diagnostics company, has scheduled the release of its second quarter 2024 financial results for August 6, 2024, after the close of the U.S. stock market. The company will also host a conference call to discuss the results and provide a business update.
2 Sources
Alarum Technologies Ltd. announced its second quarter 2024 financial results, showing revenue growth but facing challenges in the cybersecurity market. The company's stock price reacted negatively to the news.
2 Sources
iQIYI, a leading Chinese online entertainment service provider, has announced that it will release its second quarter 2024 financial results on August 22, 2024. The company will host a conference call to discuss the results with investors and analysts.
2 Sources
Tempus AI Inc., a leading AI-driven precision medicine company, has announced that it will release its second quarter 2024 financial results on August 6, 2023. The company will also host a conference call to discuss the results and provide a business update.
2 Sources
Conduent Incorporated, a business process services and solutions company, has announced the date for its second-quarter 2024 financial results release and conference call.
2 Sources